European Medical Solutions (ALEMS.BR)

EUR 0.02

(-4.17%)

Long Term Debt Summary of European Medical Solutions

European Medical Solutions's latest annual long term debt in 2023 was 12.71 Million EUR , up 22.98% from previous year.
European Medical Solutions's latest quarterly long term debt in 2023 FY was 12.71 Million EUR , up 22.98% from previous quarter.
European Medical Solutions reported annual long term debt of 10.34 Million EUR in 2022, up 12.75% from previous year.
European Medical Solutions reported annual long term debt of 9.17 Million EUR in 2021, up 3259.34% from previous year.
European Medical Solutions reported quarterly long term debt of 12.71 Million EUR for 2023 Q4, up 29.95% from previous quarter.
European Medical Solutions reported quarterly long term debt of 12.71 Million EUR for 2023 FY, up 22.98% from previous quarter.

Annual Long Term Debt Chart of European Medical Solutions (2023 - 2013)

Historical Annual Long Term Debt of European Medical Solutions (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	12.71 Million EUR	22.98%
2022	10.34 Million EUR	12.75%
2021	9.17 Million EUR	3259.34%
2020	273 Thousand EUR	-11.07%
2019	307 Thousand EUR	-33.98%
2018	465 Thousand EUR	7.64%
2017	432 Thousand EUR	3.1%
2016	419 Thousand EUR	0.0%
2015	- EUR	0.0%
2014	- EUR	-100.0%
2013	885 Thousand EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q2	9.78 Million EUR	-5.37%
2023 Q4	12.71 Million EUR	29.95%
2023 FY	12.71 Million EUR	22.98%
2022 Q4	10.34 Million EUR	-9.59%
2022 Q2	11.43 Million EUR	0.0%
2021 Q2	- EUR	-100.0%
2021 Q4	- EUR	0.0%
2020 Q4	273 Thousand EUR	-11.36%
2020 Q2	308 Thousand EUR	0.33%
2019 Q2	508 Thousand EUR	9.25%
2019 Q4	307 Thousand EUR	-39.57%
2018 Q2	446 Thousand EUR	3.24%
2018 Q4	465 Thousand EUR	4.26%
2017 Q4	432 Thousand EUR	-1.14%
2017 Q2	437 Thousand EUR	4.3%
2016 Q2	- EUR	0.0%
2016 Q4	419 Thousand EUR	0.0%
2015 Q4	- EUR	0.0%

Peer Long Term Debt Comparison of European Medical Solutions

Name	Long Term Debt	Long Term Debt Difference
Nicox S.A.	25.15 Million EUR	49.445%
FERMENTALG	14.33 Million EUR	11.313%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-80.882%